tiprankstipranks
Trending News
More News >

Waystar initiated with a Buy at TD Cowen

TD Cowen analyst Charles Rhyee initiated coverage of Waystar (WAY) with a Buy rating and $51 price target Waystar is a leading provider of software-as-a-service products for healthcare providers, including patient payments and clearinghouse solutions, the analyst tells investors in a research note. The firm believes the company should benefit from favorable underlying fundamentals, including complex billing processes and rising out-of-pocket patient costs.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1